TSH levels and risk of miscarriage in women on long-term levothyroxine: A community-based study

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 10, 2014, Pages 3895-3902

  Taylor, Peter N ^a,b   Minassian, Caroline ^d   Rehman, Anis ^e   Iqbal, Ahmed ^c   Draman, Mohd Shazli ^a   Hamilton, William ^f   Dunlop, Diana ^g   Robinson, Anthony ^g   Vaidya, Bijay ^h   Lazarus, John H ^a   Thomas, Sara ^d   Dayan, Colin M ^a,c   Okosieme, Onyebuchi E ^a,i  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Department of Social and Community Medicine ^*  (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e Akron General Center for Family Medicine   (United States)

^f UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^g ROYAL UNITED HOSPITAL   (United Kingdom)

^h UNIVERSITY OF EXETER   (United Kingdom)

ⁱ PRINCE CHARLES HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; COHORT ANALYSIS; COMMUNITY SAMPLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MIDDLE AGED; PREGNANCY OUTCOME; PRESCRIPTION; RISK FACTOR; SOCIAL STATUS; SPONTANEOUS ABORTION; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; YOUNG ADULT; ABORTION, SPONTANEOUS; ADOLESCENT; BLOOD; DEMOGRAPHY; EPIDEMIOLOGY; METABOLISM; PREGNANCY; SECOND TRIMESTER PREGNANCY;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; RESIDENCE CHARACTERISTICS; RISK FACTORS; THYROTROPIN; THYROXINE; YOUNG ADULT;

EID: 84907627038     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1954     Document Type: Article

References (38)

1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-534.
2. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43:55-68.
3. Vaidya B, Pearce S. Management of hypothyroidism in adults. BMJ. 2008;337:a801.
4. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351:241-249.
5. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18:404-433.
6. Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med. 1990;323:91-96.
7. Yassa L, Marqusee E, Fawcett R, Alexander EK. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab. 2010;95:3234-3241.
8. Idris I, Srinivasan R, Simm A, Page RC. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol (Oxf). 2005;63:560-565.
9. McClain MR, Lambert-Messerlian G, Haddow JE, et al. Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study. Am J Obstet Gynecol. 2008;199:129 e121-e126.
10. Hallengren B, Lantz M, Andreasson B, Grennert L. Pregnant women on thyroxine substitution are often dysregulated in early pregnancy. Thyroid. 2009;19:391-394.
11. Vadiveloo T, Mires GJ, Donnan PT, Leese GP. Thyroid testing in pregnant women with thyroid dysfunction in Tayside, Scotland: the thyroid epidemiology, audit and research study (TEARS). Clin Endocrinol (Oxf). 2013;78:466-471.
12. Granfors M, Akerud H, Berglund A, Skogo J, Sundstrom-Poromaa I, Wikstrom AK. Thyroid testing and management of hypothyroidism during pregnancy: a population-based study. J Clin Endocrinol Metab. 2013;98:2687-2692.
13. Khan I, Witczak JK, Hadjieconomou S, Okosieme OE. Preconception thyroid-stimulating hormone and pregnancy outcomes in women with hypothyroidism. Endocr Pract. 2013;19:656-662.
14. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12:63-68.
15. Schneuer FJ, Nassar N, Tasevski V, Morris JM, Roberts CL. Association and predictive accuracy of high TSH serum levels in first trimester and adverse pregnancy outcomes. J Clin Endocrinol Metab. 2012;97:3115-3122.
16. Korevaar TI, Schalekamp-Timmermans S, de Rijke YB, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the Generation R Study. J Clin Endocrinol Metab. 2013;98:4382-4390.
17. Ghassabian A, Bongers-Schokking JJ, Henrichs J, et al. Maternal thyroid function during pregnancy and behavioral problems in the offspring: the Generation R Study. Pediatr Res. 2011;69:454-459.
18. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341:549-555.
19. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31:702-755.
20. Okosieme OE, Marx H, Lazarus JH. Medical management of thyroid dysfunction in pregnancy and the postpartum. Exp Opin Pharmacother. 2008;9:2281-2293.
21. Vissenberg R, van den Boogaard E, van Wely M, et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Human Reprod Update. 2012;18:360-373.
22. Reid SM, Middleton P, Cossich MC, Crowther CA. Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database Syst Rev (Online). 2010: CD007752.
23. Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012;366:493-501.
24. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab. 2006;91:2587-2591.
25. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2543-2565.
26. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab. 2010;95:E44-E48.
27. Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2007;92:S1-S47.
28. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21:1081-1125.
29. Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract. 1993;43:107-109.
30. Okosieme OE, Belludi G, Spittle K, Kadiyala R, Richards J. Adequacy of thyroid hormone replacement in a general population. QJM. 2011;104:395-401.
31. Taylor PN, Iqbal A, Minassian C, et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 2014;174:32-39.
32. Walley T, Mantgani A. The UK General Practice Research Database. Lancet. 1997;350:1097-1099.
33. National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage, clinical guideline CG154, London NICE, 2012. http://guidance.nice.org.uk/CG154. Accessed February 19, 2014.
34. Haymart MR. The role of clinical guidelines in patient care: thyroid hormone replacement in women of reproductive age. Thyroid. 2010;20:301-307.
35. Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28:437-443.
36. Vaidya B, Hubalewska-Dydejczyk A, Laurberg P, Negro R, Vermiglio F, Poppe K. Treatment and screening of hypothyroidism in pregnancy: results of a European survey. Eur J Endocrinol. 2012;166:49-54.
37. Abalovich M, Alcaraz G, Kleiman-Rubinsztein J, et al. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid. 2010;20:1175-1178.
38. Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. Sub clinical hyperthyroidism and pregnancy out comes. Obstetr Gynecol. 2006;107:337-341.